Sun Pharmaceutical Q3 net up 91% at Rs 668.3 cr

Subscribe to GoodReturns

Sun Pharmaceutical Q3 net up 91%
Drug major Sun Pharmaceutical Industries Ltd said it witnessed a growth of 90.86 per cent in consolidated net profits after minority interest for the third quarter ended December 31, 2011 at Rs 668.3 crore.

The company had posted a net profit after minority interest of Rs 350.15 crore during the same period a year ago, said Sun Pharmaceutical Industries in its filing to the Bombay Stock Exchange on February 13, 2012.

Besides, the total income of the company increased by 29.69 per cent to Rs 2058.79 crore during Q3 FY12, as compared to Rs 1587.47 crore during Q3 FY11.

Buoyed by the impressive resultson Monday, shares of the company closed at Rs 551 a piece, up 1.79 per cent from previous close on BSE.

Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?